PJs

(redirected from STK11)
Also found in: Medical.

PJs

or PJ's or pj's  (pē′jāz′)
pl.n. Informal
Pajamas.

[p(a)j(ama)s, pl. of pajama.]

PJs

(piːˈdʒeɪz) or

pj's

pl n
pyjamas

pa•ja•mas

(pəˈdʒɑ məz, -ˈdʒæm əz)

n. (used with a pl. v.)
1. nightclothes consisting of loose-fitting trousers and a jacket.
2. loose trousers of silk, cotton, etc., orig. worn in India and parts of the Middle East.
Also, esp. Brit., pyjamas.
[1870–75; pl. of pajama < Hindi, variant of pāyjāma < Persian pāy leg + jāma garment]
pa•ja′maed, adj.
Translations

pjs

pj's [ˈpiːdʒeɪz] npl (=pyjamas) → pyj m
Mentioned in ?
References in periodicals archive ?
48) In addition, somatic mutations of STK11 are identified in more than half of the sporadic cases.
Genes Tested AtP ALK APC ATM BAP1 BRCA2 BRIP1 BUB1B CDC73 CDH1 CEP57 CHEK2 CYLD DDB2 DICER1 ERCC3 ERCC4 ERCC5 EXT1 EXT2 FANCD2 FANCE FANCF FANCG FANCI GATA2 GPC3 HNF1A HOXB13 HRAS MLH1 MHS2 MSH6 MUTYH NBN PHOX2B PMS1 PMS2 PPM1D PRF1 RAD51D RBI RECQL4 RET RHBDF2 SDHC SDHD SLX4 SMAD4 SMARCA4 TP53 TSC1 TSC2 VHL WT1 BARD1 BLM BMPR1A BRCA1 CDK4 CDKN1C CDKN2A CEBPA DI53L2 EGFR EPCAM ERCC2 EZH2 FANCA FANCB FANCC FANCL FANCM FH FLCN KIT MAX MEN1 MET NF1 NF2 NSD1 PALB2 PRKAR1A PTCH1 PTEN RAD51C RUN XI SBDS SDHAF2 SDHB SMARCB1 STK11 5UFU TMEM127 WRN XPA XPC This chart shows all 98 cancer susceptible genes included in this new test.
Genetic variations in STK11, PRKAA1, and TSC1 associated with prognosis for patients with colorectal cancer.
8] Human genes: EGFR, epidermal growth factor receptor; KRAS, KRAS proto-oncogene, GTPase; TP53, tumor protein p53; ERBB2, erb-b2 receptor tyrosine kinase 2; DDR2, discoidin domain receptor tyrosine kinase 2; STK11, serine/threonine kinase 11.
have demonstrated that it is possible to distinguish an LCNEC SCLC-like group, carrying MYCL1 amplifications and mutations in both RB1 and TP53 genes from an AD/SQ-like group, harboring CDKN2A deletions, TTF1 amplifications, and frequent mutations in KEAP1 and STK11.
Son varios los genes que confieren predisposicion al cancer de mama, incluyendo las variantes en los genes: TP53, PTEN, STK11 y CDH1 (5); sin embargo, las variantes geneticas de los genes BRCA1 y BRCA2, ubicados en los cromosomas 17q y 13q respectivamente, son las mas prevalentes, siendo responsables de cerca del 30% de los casos de HBOC (5, 6).
2) Peutz-Jeghers syndrome due to mutations in the STK11 tumor suppressor gene (very rare, but a very strong risk factor).
Impact of KCNJ11 TCF7L2 SLC30A8 IGF2BP2 PPARG SLC47A1 STK11 HHEX KCNQ1 CDKAL1 FTO CYP2C9 ADIPOQ CAPN10 gene polymorphisms on risk of type 2 diabetes and therapeutic response to sulfonylurea and metformin therapy.
It screens for mutations in the BRCA1 and BRCA2 genes as well as in five additional genes, namely TP53, PTEN, CDH1, STK11, and PALB2.
5) Highly penetrant genetic mutations in TP53 (Li-Fraumeni syndrome), PTEN (Cowden syndrome), CDH1 (Hereditary Diffuse Gastric Cancer syndrome), and STK11 (Peutz Jeghers syndrome) have long been recognized as possible causes of hereditary breast cancer, and now panel testing includes these along with moderately penetrant genes such as checkpoint kinase 2 (CHEK2), ATM serine/ thereonine kinase (ATM), and partner and localizer of BRCA2 (PALB2).
5 (AD and AR) lymphoma, leukaemia STK11 Colorectal 0.